Literature DB >> 10755810

Psychoacoustic measures of tinnitus.

J A Henry1, M B Meikle.   

Abstract

This report reviews research from the 1930s to the present that has extended our understanding by investigating the characteristics of tinnitus that can be studied using psychoacoustic techniques. Studies of tinnitus masking and residual inhibition began in the 1970s, leading to the therapeutic use of tinnitus masking and a consequent increase in research devoted to tinnitus measurement. In 1981, the CIBA Foundation symposium on tinnitus advocated general adoption of four tinnitus measures: (1) pitch, (2) loudness, (3) maskability, and (4) residual inhibition. Since then, psychoacoustic research into all four topics has proliferated, yielding many valuable insights and controversies concerning the details of measurement techniques. A consensus has emerged that neither the loudness nor other psychoacoustic measures of tinnitus bear a consistent relation to the severity or perceived loudness of tinnitus. Nevertheless, quantification is needed in clinical trials of proposed treatments and in a variety of other types of tinnitus research. Standardization of techniques for specifying the acoustic parameters of tinnitus thus continues to be an important research goal.

Entities:  

Mesh:

Year:  2000        PMID: 10755810

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  67 in total

1.  The comparison of acoustic and psychic parameters of subjective tinnitus.

Authors:  Erkan Karatas; Murat Deniz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-03       Impact factor: 2.503

2.  COVID-19 associated anxiety enhances tinnitus.

Authors:  Li Xia; Gang He; Yong Feng; Xiaoxu Yu; Xiaolong Zhao; Shankai Yin; Zhengnong Chen; Jian Wang; Jiangang Fan; Chuan Dong
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

3.  Tinnitus outcomes assessment.

Authors:  Mary B Meikle; Barbara J Stewart; Susan E Griest; James A Henry
Journal:  Trends Amplif       Date:  2008-07-03

4.  Individual patient factors associated with effective tinnitus treatment.

Authors:  Sarah M Theodoroff; Andrew Schuette; Susan Griest; James A Henry
Journal:  J Am Acad Audiol       Date:  2014 Jul-Aug       Impact factor: 1.664

Review 5. 

Authors:  Vincent Wu; Bonnie Cooke; Susan Eitutis; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2018-07       Impact factor: 3.275

6.  Moderate therapeutic efficacy of positron emission tomography-navigated repetitive transcranial magnetic stimulation for chronic tinnitus: a randomised, controlled pilot study.

Authors:  C Plewnia; M Reimold; A Najib; G Reischl; S K Plontke; C Gerloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08-04       Impact factor: 10.154

7.  Changes over time of psychoacoustic outcome measurements are not a substitute for subjective outcome measurements in acute tinnitus.

Authors:  Sarah Rabau; Tony Cox; Andrea Kleine Punte; Brecht Waelkens; Annick Gilles; Kristien Wouters; Sebastien Janssens de Varebeke; Paul Van de Heyning
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-07       Impact factor: 2.503

8.  The Emotional and Functional Impact of the Type of Tinnitus Sensation.

Authors:  John Moring; Anne Bowen; Jenifer Thomas; Lindsay Bira
Journal:  J Clin Psychol Med Settings       Date:  2016-09

9.  Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006.

Authors:  B Langguth; R Goodey; A Azevedo; A Bjorne; A Cacace; A Crocetti; L Del Bo; D De Ridder; I Diges; T Elbert; H Flor; C Herraiz; T Ganz Sanchez; P Eichhammer; R Figueiredo; G Hajak; T Kleinjung; M Landgrebe; A Londero; M J A Lainez; M Mazzoli; M B Meikle; J Melcher; J P Rauschecker; P G Sand; M Struve; P Van de Heyning; P Van Dijk; R Vergara
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

Review 10.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.